Innovating
affordable
medicine
Our expanding portfolio of generic, evolved formulation, and biosimilar products is reducing access barriers to therapies your patients have been prescribed.
Supporting
sustainability
As healthcare costs rise, we strive to develop high-quality, affordable treatment options for a more sustainable supply chain of essential medicines.
Growing oncology
portfolio
We're passionate about providing patients with the treatments they need.
Delivering
value
Our medicines offer patients and providers increased choice, access, and affordability.
“
Our actions are framed by prioritizing patients and the HCPs who treat them. We value the trust providers place in Amneal when they choose our biosimilars for their patients.
— Scott Spencer
VP, Branded Institutional Sales & Marketing
